Esophageal Neoplasms: Clinical Trials

2,318 trials for Esophageal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

848 completed, 503 unknown, 434 recruiting, 188 terminated. 875 Phase 2, 463 Phase 1, 429 Not applicable, 195 Phase 3, 30 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2875Completed 299, Unknown 200, Recruiting 164, Terminated 80, Not yet recruiting 54, Active not recruiting 45, Withdrawn 25, Enrolling by invitation 4, Suspended 4
Phase 1463Completed 182, Recruiting 96, Terminated 59, Unknown 54, Active not recruiting 38, Withdrawn 14, Not yet recruiting 13, Enrolling by invitation 4, Suspended 3
Not applicable429Completed 155, Unknown 107, Recruiting 72, Terminated 35, Not yet recruiting 24, Active not recruiting 19, Withdrawn 11, Enrolling by invitation 4, Suspended 2
Phase 3195Completed 63, Unknown 53, Recruiting 40, Not yet recruiting 15, Terminated 11, Active not recruiting 8, Withdrawn 4, Enrolling by invitation 1
Phase 430Completed 12, Unknown 12, Recruiting 2, Terminated 2, Enrolling by invitation 1, Not yet recruiting 1
Early Phase 114Unknown 4, Recruiting 3, Completed 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1

Follow Esophageal Neoplasms: new trials by email Literature Review of Esophageal Neoplasms trials Research Report on Esophageal Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adaptive Neoadjuvant Therapy for Esophageal Cancer
Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy
Not applicableEnrolling by invitationCancer Hospital Chinese Academy of Medical Science, Shenzhen Center432028-03-012025-05-25
Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer
Stereotactic body radiation treatment (SBRT) - Esophageal Cancer
Phase 2Not yet recruitingAHS Cancer Control Alberta222027-03-012026-10-28
ALDH2 Genetic Testing in East Asian Community
Genetic Test Results Return, Alcohol Flushing Education - Healthy Adult, Flushing
Not applicableNot yet recruitingNorthwestern University1002027-02-012026-10-28
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel), Simvastatin, Durvalumab - Gastroesophageal Adenocarcinoma
Phase 2Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre1842027-01-012026-07-10
Outside the Cage (OTC) Robotic Esophagectomy
OTC MIE Esophagectomy - Esophageal Cancer
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)312027-01-012026-03-18
PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC
Toripalimab, Carboplatin + Paclitaxel - Esophageal Squamous Cell Carcinoma
Phase 2Not yet recruitingVanderbilt-Ingram Cancer Center202026-12-312026-09-23
Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma
Tislelizumab - Esophageal Cancer
Phase 3Not yet recruitingAsan Medical Center1722026-12-312026-10-29
A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical Resection
SYS6010, SG001, SG001 placebo-mimicking - Esophageal Squamous Cell Carcinoma
Phase 3Not yet recruitingCSPC Megalith Biopharmaceutical Co.,Ltd.5852026-12-302026-11-09
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
LG00313112 - Ovarian Cancer, Small Cell Lung Cancer
Phase 1 / Phase 2Not yet recruitingLG Chem2502026-12-012026-08-07
Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
Zanidatamab - Esophageal Cancer, GastroEsophageal Cancer
Not yet recruitingJazz Pharmaceuticals3002026-11-302026-10-26
Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions
High-flow nasal cannula Group, Regular Nasal Cannula Group - Hypoxemia, Gastric Cancer (Diagnosis)
Not applicableNot yet recruitingDiansan Su4302026-11-022026-10-29
Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer
Enteral or parenteral nutrition - Esophageal Cancer, Surgery Indication
RecruitingUniversity Hospital, Bordeaux6702026-11-012026-05-13
Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma
Standardized Management Protocol for Esophageal Fistula - Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Fistula
Not yet recruitingPeking University Cancer Hospital & Institute322026-11-012026-11-05
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
Larotinib - Esophageal Cancer, Advanced Solid Tumor
Phase 1WithdrawnSunshine Lake Pharma Co., Ltd.2026-10-302026-09-28
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
PF-08098488 - Pancreatic Ductal Adenocarcinoma, Esophageal Cancer
Phase 1RecruitingPfizer2802026-10-292026-11-03
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) - Esophageal Adenocarcinoma
Phase 2RecruitingDuke University602026-10-212026-11-04
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
CR-002 - Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ
Phase 1 / Phase 2RecruitingCrescent Biopharma, Inc.2192026-10-212026-11-02
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
STRO-006, Pembrolizumab - Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer
Phase 1RecruitingSutro Biopharma, Inc.2852026-10-192026-10-23
Modular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
Modular Robot-Assisted Esophagectomy, Conventional Minimally Invasive Esophagectomy - Esophageal Cancer
Phase 3RecruitingRuijin Hospital1602026-10-152026-10-22
A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)
anlotinib + PD-1 inhibitor, PD-1 inhibitor - Esophageal Cancer (EC)
Phase 2RecruitingSun Yat-sen University1122026-10-122026-10-07

Showing 20 of 2318. Sign in to see all of them.

Narrower conditions

Esophageal Squamous Cell Carcinoma (626)  ·  Stomach Neoplasms (574)  ·  Pancreatic Neoplasms (248)  ·  Carcinoma, Non-Small-Cell Lung (227)  ·  Adenocarcinoma Of Esophagus (205)  ·  Lung Neoplasms (204)  ·  Colorectal Neoplasms (201)  ·  Breast Neoplasms (177)  ·  Ovarian Neoplasms (161)  ·  Neoplasms (149)  ·  Head and Neck Neoplasms (141)  ·  Uterine Cervical Neoplasms (141)  ·  Colonic Neoplasms (125)  ·  Urinary Bladder Neoplasms (123)

Broader conditions

Digestive System Diseases (2310)  ·  Neoplasms by Site (2310)  ·  Digestive System Neoplasms (2306)  ·  Gastrointestinal Diseases (2306)  ·  Esophageal Diseases (2298)  ·  Gastrointestinal Neoplasms (2259)  ·  Head and Neck Neoplasms (2177)  ·  Neoplasms (2169)  ·  Neoplasms by Histologic Type (968)  ·  Neoplasms, Glandular and Epithelial (915)  ·  Carcinoma (862)  ·  Carcinoma, Squamous Cell (680)  ·  Neoplasms, Squamous Cell (651)  ·  Stomach Diseases (576)

Interventions

Cisplatin (238)  ·  Paclitaxel (181)  ·  Radiotherapy (174)  ·  Fluorouracil (165)  ·  Carboplatin (110)  ·  Oxaliplatin (100)  ·  pembrolizumab (91)  ·  Docetaxel (86)  ·  Irinotecan (78)  ·  Drug Therapy (72)  ·  Capecitabine (70)  ·  Leucovorin (64)  ·  Radiation (61)  ·  Esophagectomy (58)  ·  Surgical Procedures, Operative (51)

Sponsors

Fudan University (54)  ·  National Cancer Institute (NCI) (48)  ·  Sun Yat-sen University (47)  ·  Memorial Sloan Kettering Cancer Center (41)  ·  Tianjin Medical University Cancer Institute and Hospital (33)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (29)  ·  M.D. Anderson Cancer Center (29)  ·  National Taiwan University Hospital (28)  ·  Chinese Academy of Medical Sciences (27)  ·  Alliance for Clinical Trials in Oncology (22)  ·  Shanghai Chest Hospital (22)  ·  Henan Cancer Hospital (21)  ·  Zhejiang Cancer Hospital (21)  ·  Peking University (20)  ·  Shanghai Zhongshan Hospital (20)

Countries

China (797)  ·  United States (743)  ·  United Kingdom (131)  ·  France (123)  ·  Taiwan (107)  ·  Germany (99)  ·  Netherlands (97)  ·  South Korea (95)  ·  Canada (91)  ·  Japan (85)  ·  Spain (82)  ·  Italy (68)  ·  Belgium (58)  ·  Australia (52)  ·  Denmark (39)

Top investigators

David H. Ilson, MD, PhD (11)  ·  Aminah Jatoi, MD (8)  ·  David S Schrump, M.D. (8)  ·  Feng Wang (7)  ·  Lin Shen, MD (7)  ·  Yelena Janjigian, MD (7)  ·  Peter Enzinger, MD (6)  ·  Zefen Xiao, MD (6)

Results publications

PMID 33538338, PMID 22646630, PMID 26808342, PMID 36990609, PMID 26254683, PMID 30089078, PMID 18309943, PMID 21684205, PMID 26313683, PMID 33373868, PMID 34454674, PMID 35623069, PMID 41309527, PMID 10235156, PMID 11208820, PMID 11870157, PMID 19465425, PMID 21839994, PMID 23148692, PMID 24224128, PMID 24371038, PMID 24612702, PMID 24982463, PMID 25668428, PMID 25691612, PMID 26805559, PMID 27223606, PMID 27266524, PMID 27742014, PMID 28742685, PMID 29799976, PMID 30207593, PMID 30291834, PMID 30308612, PMID 32768158, PMID 33026938, PMID 33553366, PMID 33674602, PMID 33813524, PMID 34160577, PMID 34351356, PMID 35440464, PMID 36812121, PMID 37139963, PMID 37195667, PMID 37488287, PMID 37496366, PMID 37932848, PMID 38710003, PMID 39221992

NIH funding

2023 (21), 2019 (11), 2017 (9), 2014 (5), 2015 (5), 2018 (5), P30CA008748 (5), P30CA043703 (5), P30CA068485 (5), U10CA032102 (5), 2016 (4), 2025 (4), U10CA021115 (4), P30CA015083 (3), P30CA016056 (3)